Literature DB >> 2078972

In vitro generation of carbon monoxide from organic molecules and synthetic metalloporphyrins mediated by light.

H J Vreman1, M J Gillman, K R Downum, D K Stevenson.   

Abstract

Tin protoporphyrin (SnPP) and analogs are being studied as possible agents for the prevention of neonatal hyperbilirubinemia through inhibition of heme oxygenase. Because SnPP is a photosensitizer, we studied its role in the photogeneration of carbon monoxide (CO) from organic compounds in vitro. Generation of CO occurred in the presence of 5 microM SnPP and cool white light (19 muW/cm2/nm or 29 W/m2) from SnPP alone, human serum albumin, glucose, histidine, ethanolamine, medium-chain triglycerides, the reduced form of nicotinamide-adenine dinucleotide phosphate (NADPH), and human plasma. More detailed studies with human serum albumin and NADPH established that the photogeneration of CO is nearly linear with time and irradiance. It is curvilinear with respect to the SnPP concentration at the concentrations tested, and it is dependent on the presence of O2 in the reactor headspace. Cool white light generated less CO from human serum albumin and NADPH than equidistantly placed blue and green phototherapy light sources. Comparison of SnPP with other metalloporphyrin heme oxygenase inhibitors indicates that tin mesoporphyrin is most and zinc protoporphyrin least photoreactive.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2078972     DOI: 10.1159/000457630

Source DB:  PubMed          Journal:  Dev Pharmacol Ther        ISSN: 0379-8305


  10 in total

1.  Dependence of acetylcholine and ADP dilation of pial arterioles on heme oxygenase after transfusion of cell-free polymeric hemoglobin.

Authors:  Annette Rebel; Suyi Cao; Herman Kwansa; Sylvain Doré; Enrico Bucci; Raymond C Koehler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-10-07       Impact factor: 4.733

2.  Selectivity of imidazole-dioxolane compounds for in vitro inhibition of microsomal haem oxygenase isoforms.

Authors:  Robert T Kinobe; Jason Z Vlahakis; Hendrik J Vreman; David K Stevenson; James F Brien; Walter A Szarek; Kanji Nakatsu
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

Review 3.  Carbon monoxide detection and biological investigations.

Authors:  D K Stevenson; H J Vreman; R J Wong; P A Dennery; C H Contag
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

Review 4.  Metalloporphyrins in the management of neonatal hyperbilirubinemia.

Authors:  David K Stevenson; Ronald J Wong
Journal:  Semin Fetal Neonatal Med       Date:  2009-12-16       Impact factor: 3.926

5.  Inhibition by zinc protoporphyrin-IX of receptor-mediated relaxation of the rat aorta in a manner distinct from inhibition of haem oxygenase.

Authors:  L Ny; K E Andersson; L Grundemar
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

6.  Role of heme oxygenase-2 in pial arteriolar response to acetylcholine in mice with and without transfusion of cell-free hemoglobin polymers.

Authors:  Xinyue Qin; Herman Kwansa; Enrico Bucci; Sylvain Doré; Darren Boehning; David Shugar; Raymond C Koehler
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-05-21       Impact factor: 3.619

7.  Dermal carbon monoxide excretion in neonatal rats during light exposure.

Authors:  Hendrik J Vreman; Yuri Knauer; Ronald J Wong; Miu-Lan Chan; David K Stevenson
Journal:  Pediatr Res       Date:  2009-07       Impact factor: 3.756

8.  Clinical trial of tin mesoporphyrin to prevent neonatal hyperbilirubinemia.

Authors:  V K Bhutani; R Poland; L D Meloy; T Hegyi; A A Fanaroff; M J Maisels
Journal:  J Perinatol       Date:  2016-03-03       Impact factor: 2.521

9.  Metalloporphyrins - an update.

Authors:  Stephanie Schulz; Ronald J Wong; Hendrik J Vreman; David K Stevenson
Journal:  Front Pharmacol       Date:  2012-04-26       Impact factor: 5.810

Review 10.  Efficacy and Safety Concerns with Sn-Mesoporphyrin as an Adjunct Therapy in Neonatal Hyperbilirubinemia: A Literature Review.

Authors:  Prakar Poudel; Sudhir Adhikari
Journal:  Int J Pediatr       Date:  2022-07-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.